U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT06984887) titled 'Evaluation of New TB Diagnostic Tests (NATs) in Pakistan' on May 14.
Brief Summary: This study aims to test new diagnostic methods for tuberculosis (TB) testing as compared to the existing Xpert MTB/Rif Ultra testing approach. The research questions that will be addressed by this study include:
* What are the sensitivity and specificity of the new diagnostic tests Pluslife MTBC and Ustar PortNAT for tuberculosis and how do these compare to Xpert Ultra?
* How does the new diagnostic method compare to Xpert Ultra in terms of implementation feasibility, cost and turnaround time?
* What are the logistical and technical advantages and ...